Evidence map›Paper›PMID 39362720›Full record

ReviewClinics in liver disease2024

Treatment of Alcohol Use Disorder: Behavioral and Pharmacologic Therapies.

Kinza Tareen, Erin G Clifton, Ponni Perumalswami, Jessica L Mellinger, Gerald Scott Winder

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Clinics in liver disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kinza TareenDepartment of Psychiatry, University of Michigan, Ann Arbor, MI, USA. Electronic address: tkinza@med.umich.edu.
Erin G CliftonDepartment of Psychiatry, University of Michigan, Ann Arbor, MI, USA.
Ponni PerumalswamiGastroenterology Section, Veterans Affairs, Ann Arbor Healthcare System, Ann Arbor, MI, USA; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
Jessica L MellingerDepartment of Psychiatry, University of Michigan, Ann Arbor, MI, USA; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
Gerald Scott WinderDepartment of Psychiatry, University of Michigan, Ann Arbor, MI, USA; Department of Surgery, University of Michigan, Ann Arbor, MI, USA; Department of Neurology, University of Michigan, Ann Arbor, MI, USA.

Funding

Adaptive Interventions to Improve Alcohol Treatment Engagement among Alcohol-related Liver Disease PatientsR01AA030748 · NIAAA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Jessica Leigh Mellinger · 2023 to 2026
$2.6M
Improving Outcomes in Alcoholic Liver Disease: Integrating Behavioral Interventions into the Hepatology ClinicK23AA026333 · NIAAA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MELLINGER, JESSICA LEIGH · 2018 to 2022
$972k
NIAAA NIH HHS K23 AA026333NIAAA NIH HHS L30 AA026149NIAAA NIH HHS R01 AA030748
6 · The paper itself

Abstract

The prevalence of alcohol use disorder (AUD) has significantly increased over the last decade, leading to an increase in alcohol-associated liver disease (ALD) rates worldwide. Despite this prominence, AUD in ALD remains undertreated and carries significant implications in the progression to end-stage ALD and increased mortality. In efforts to bridge this gap, interprofessional and integrated AUD treatment is necessary for patients with ALD to ensure early detection and an appropriately targeted level of care. Although pharmacotherapy, psychotherapy, and psychosocial interventions independently play a role in treating AUD, a combination of these evidence-based modalities often results in lasting change.

Indexed as

Alcohol DeterrentsAlcoholismAcamprosateAlcohol-Related DisordersBehavior TherapyCognitive Behavioral TherapyDisulfiramHumansLiver Diseases, AlcoholicNaltrexonePsychotherapyAcamprosateAlcohol DeterrentsDisulfiramNaltrexoneAlcohol liver diseaseAlcohol use disorderAlcohol use disorder pharmacotherapiesAlcohol use disorder psychotherapyPsychiatric comorbidities

Identifiers

PMID39362720
PMCPMC11450263

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.